Kelli Luginbuhl
Biotech Founder in Residence
Kelli Luginbuihl joins us with a strong background in the biotech industry. She is the Co-Founder and former CSO turned CEO of Isolere Bio, a company that has been at the forefront of developing enabling manufacturing technology for advanced therapeutics. Kelli played a crucial role in bootstrapping Isolere Bio with various forms of non-dilutive funding until its successful Series Seed round. In February 2023, Isolere was acquired by Donaldson, where Kelli led the integration efforts and now serves as General Manager. Kelli holds a B.S. in Chemical Engineering from Colorado State University and both an M.S. and Ph.D. in Biomedical Engineering from Duke University. Her expertise in scaling biotech startups and navigating the complexities of acquisition and integration will be a tremendous asset to CED and our community.